Kirkland & Ellis advised Heron Therapeutics on the deal.Heron Therapeutics, Inc. (NASDAQ: HRTX) announced that it has entered into a cooperation agreement with two of its shareholders,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now